Loading the section
The price of Utah Medical Products, Inc. (UTMD) on October 9, 2026 is 74.54 USD, +0.89% on the day. Over 52 weeks the stock traded between 53.66 USD and 76.89 USD; the price now sits 90% of the way up that range. Over the past year the price changed by +17.52%. The P/E ratio is 21.9, which is below the sector median (25.0). Market capitalization is 237.34 million USD, rank 56 among 98 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: 22 October 2026 · Earnings calendar
Utah Medical Products, Inc. trades on Nasdaq under the ticker UTMD. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks UTMD has traded between 53.66 $ and 76.89 $. As of 09 October 2026 the price stood 89.88 % of the way from the 52-week low to the high.
Over one year UTMD shares rose 17.52 %; over six months they rose 13.11 %. Volatility over 90 days is 36.57 %. Dividends are not included: this is price change only, as of 09 October 2026.
UTMD trades at a price-to-earnings ratio of 21.9, below the sector median of 25.0. Price to sales is 6.3, above the sector median of 4.0. Price to book is 2.0, below the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 74.00 | 74.83 | 73.75 | 74.54 | 45,300 |
| 08 October 2026 | 73.50 | 74.02 | 73.47 | 73.88 | 32,700 |
| 07 October 2026 | 74.00 | 74.21 | 73.39 | 73.45 | 67,000 |
| 06 October 2026 | 73.50 | 74.18 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
No news about this security in English yet.
Address:7043 S 300 WEST, MIDVALE, UT, 84070, US
Utah Medical Products, Inc. reported revenue of 38M $ and net income of 11M $ over the last four quarters. Net margin is 28.90 %. Revenue changed by −4.43 % year over year. Earnings per share are 3.38 $. Market capitalisation is 237M $.
UTMD has a return on equity of 9.01 %, above the sector median of −41.68 %. Return on assets is 8.72 %, above the sector median of −32.11 %. Operating margin is 28.81 %, above the sector median of −26.84 %.
Utah Medical Products, Inc. pays dividends quarterly: 1.24 $ per share over the past twelve months, a yield of 1.66 %. The latest payment was 0.31 $, with an ex-dividend date of 17 September 2026. The company has raised its payout for 4 years in a row.
| 328M |
| DXCMDexCom, Inc. | 84.11 | −0.36 % | 324M |
| MDLNMedline Inc. | 36.26 | +1.45 % | 297M |
| RMDResMed Inc. | 230.05 | +1.46 % | 271M |
| PODDInsulet Corporation | 135.28 | +0.60 % | 244M |
| 73.50 |
| 73.83 |
| 63,000 |
| 05 October 2026 | 74.22 | 74.28 | 73.22 | 73.31 | 33,900 |
| 02 October 2026 | 74.40 | 74.43 | 74.13 | 74.13 | 19,600 |
| 01 October 2026 | 74.44 | 74.51 | 74.07 | 74.35 | 18,900 |
| 30 September 2026 | 74.95 | 74.95 | 74.04 | 74.05 | 30,000 |
| 29 September 2026 | 74.57 | 74.95 | 74.25 | 74.95 | 29,900 |
| 28 September 2026 | 74.18 | 74.54 | 73.75 | 74.49 | 31,400 |
| 25 September 2026 | 74.70 | 74.70 | 74.12 | 74.18 | 22,500 |
| 24 September 2026 | 75.50 | 75.55 | 74.30 | 74.75 | 42,100 |
| 23 September 2026 | 76.55 | 76.55 | 74.84 | 75.01 | 23,800 |
| 22 September 2026 | 74.77 | 76.89 | 74.75 | 76.66 | 56,200 |
| 21 September 2026 | 74.16 | 74.80 | 73.70 | 74.48 | 28,600 |
| 18 September 2026 | 74.14 | 74.48 | 73.95 | 73.96 | 42,300 |
| 17 September 2026 | 75.13 | 75.13 | 74.04 | 74.19 | 24,900 |
| 16 September 2026 | 74.59 | 74.78 | 73.74 | 74.06 | 19,100 |
| 15 September 2026 | 71.28 | 74.79 | 70.35 | 74.63 | 64,200 |
| 14 September 2026 | 69.71 | 71.26 | 69.49 | 70.67 | 57,700 |